Teva's US IUD Brings In $1.1bn For The Embattled Generics Firm

 
• By John Davis

Teva’s planned divestment of non-core assets in order to refocus the company after a troubled first-half has started with a contraceptive device.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.

More from Strategy

More from Business